Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin for Physical and Cognitive Functioning in Elders
NCT02069431Phase 1Terminated
- Sponsor
- University of Florida
- Start
- Feb 2016
- Primary completion
- May 2020
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of oxytocin nasal spray in inflammation (2 arms), sponsored by University of Florida. Primary endpoint: Inflammatory biomarkers at Day 28. Started Feb 2016; status: terminated.
02
Drugs
oxytocin nasal spray
03
Conditions
inflammation
Beyond the preview
Go deeper on NCT02069431.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02069431.